Transfusion Management of Massive Haemorrhage in Adults Patient bleeding / collapses Ongoing severe bleeding eg: 150 mls/min and Clinical shock Administer.

Slides:



Advertisements
Similar presentations
Coagulopathy and blood component transfusion in trauma
Advertisements

Dr James F Peerless October Objectives Management of the sick patient – Two broad categories: The sick laparotomy The major bleed.
Blood Bag Coagulation & Preservers Citrate 24 hours 1-6 ºC Heparin 48 hours 1-6 ºC ACD or CPD 21 days 1-6 ºC CPD-A135 days 1-6 ºC CPD-A1+ additive.
Trauma Anaesthesia Dr James Peerless December 2013.
Massive Transfusion Protocol
Brad Beckham T4. Definitions  Major blood loss Hemoglobin concentration below 6-10 g/dl  Massive transfusion in adults >9 erythrocyte units within 24h.
Massive transfusion: New Protocol
Dr Craig French. Anaemia is bad for you. BUT Is correction of anaemia with Red Blood Cell transfusion good for you?
Transfusion Management of massive haemorrhage in children Ongoing severe bleeding (overt / covert) and received 20ml/kg of red cells or 40ml/kg of any.
Blood Components Dosage And Their Administration
Transfusion Quiz Laboratory Staff. Q1. Name 3 patient identifiers that must be on sample taken for Transfusion? Name, ward and gender Surname, Hospital.
A/Prof Larry McNicol. Improves the patient’s own blood and avoids unnecessary transfusions. ‘THE THREE PILLARS’ Minimise blood loss Optimise blood volume.
BLOOD BANKING 1- BLOOD PRODUCTS 2- AUTOLOGOUS TRANSFUSION M. H. Shaheen Maadi Armed Forces Hospital.
ANAESTHESIA AND ANTICOAGULANTS
MAXINE BOYD HOSPITAL TRANSFUSION PRACTITIONER
Management of Massive Bleeding in the ICU
Transfusion Quiz “Their Lives in Your Hands” Doctors.
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.
HAEMATOLOGY MODULE: COAGULATION DISORDERS 1 Adult Medical-Surgical Nursing.
Transfusing tiny soldiers Ramsey C. Tate, MD. Applying combat-derived massive transfusion protocols to pediatric trauma patients.
Definition of Massive Transfusion Replacement of a blood volume equivalent within 24hr Transfusion>10 unit within 24 hr Transfusion > 4 units in 1 hr.
MTP Octaplex rFVIIa Calgary. Massive Transfusion Protocol.
Clinical Use of Blood Components Salwa Hindawi Director of Blood Transfusion Services KAUH, Jeddah KSA SITMS 24 th March 2004.
4th year medical students Blood Component Therapy Salwa I Hindawi MSc FRCPath CTM Director of Blood Transfusion Services KAUH. Jeddah.
Senior clinician Request: a o 4 units RBC o 2 units FFP Consider: a o 1 adult therapeutic dose platelets o tranexamic acid in trauma patients Include:
Massive blood transfusion
Fluids and blood products in trauma
Emergency management of complications of thrombolysis C. Roffe The recommendations in this presentation are for guidance only. Guidance based on ASA recommendations.
The Clinical Guide “A Guide to Implementing Renal Best Practice in Haemodialysis“ Chapter 5: Anticoagulation Team Leader: Angela Henson Co-authors: Franta.
Clinical Case: Mr Veri Pushi: 45 year old married self-employed property developer You are present in casualty when this gentleman is brought in by ambulance.
BLOOD TRANSFUSION NUR 317. TRANSFUSION Infusion of blood products for the purpose of restoring circulating volume.
Role of Factor Concentrates in Perioperative Coagulopathies Dr Neville Gibbs Department of Anaesthesia Sir Charles Gairdner Hospital.
Lt Col T Woolley FRCA RAMC Surg Lt Cdr Catherine Doran MRCS PGCAES RN Surg Capt M Midwinter DipAppStats MD FRCS RN NATO Medical Conference Royal Centre.
Life Support in Haemorrhage and Fluid Loss H.Gee MD, FRCOG.
Investigation of Haemostasis MS. c. program Lab-9.
The Massive Transfusion Protocol An Aide Memoire 1.
Receive call from designated communication lead in clinical area: ‘This relates to massive haemorrhage situation’ The caller will state: Communication.
Carl P. Walther*, Amber S. Podoll*, Kevin W. Finkel* *The University of Texas Health Science Center at Houston Citrate Toxicity During CRRT After Massive.
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
Blood Transfusion Safe Practice.
Fluids and Transfusion
Consultant in Haematology and Transfusion Medicine
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics Roles Senior clinician Coordinate team and allocate roles Determine volume and type.
BLOOD TRANSFUSION Ferdi Menda,M.D. Assistant Prof of Anesthesiology Yeditepe University.
Transfusion Christine Sullivan Transfusion Practitioner.
Plasma and plasma components in the management of disseminated intravascular coagulation Marcel Levi* Academic Medical Center, University of Amsterdam,
Guidelines on the Management of Massive Blood Loss British Committee for Standards in Haematology Date for guideline review July 2008 Dr khawla Belhoul.
Systemic anticoagulation during ECMO is intended to control thrombin generation and limit the risk for thrombotic and hemorrhagic complications.
Dr David Highton Anaesthetic Registrar UCL Hospitals Fluids An Introduction to Anaesthesia 2016.
Consultant Anaesthetist Department of Anaesthesia
Evaluation of the capacity of the trauma induced coagulopathy clinical score (ticcs) TO identify trauma patients presenting early acute coagulopathy evaluated.
K A U H Blood bank Wesaam Al-Sheyyab.
AUB:Iatrogent Coagulopathy
Audit of Blood Product Use in Paediatric Cardiac Bypass Surgery.
Warfarin Toxicity Treatment & Management
Denver Health Medical Center’s Massive Transfusion Protocol
Trauma Blood Product Preparation and Delivery Improvement
BLOOD TRANSFUSION PETER HUDSON CLINICAL SPECIALIST.
Warfarin therapy does not increase bleeding in patients undergoing heart transplantation  Cullen D Morris, MD, J.David Vega, MD, Jerrold H Levy, MD, Nancy.
Reversal of Direct Oral Anticoagulants (DOAC)
Fellowship trial exam Question 26
Reversal by the specific antidote, idarucizumab, of elevated dabigatran exposure in a patient with rectal perforation and paralytic ileus  C. Thorborg,
Algorithm for Reviewing Requests for Red Cells
Intraoperative Cell Salvage
Anticoagulant Reversal
RETROSPECTIVE ANALYSIS OF MASSIVE TRANSFUSION PRACTICE IN NON-TRAUMA RELATED HEMORRHAGIC SHOCK IN A TERTIARY CARE CENTRE Dr. Gayathri.A.M, Dr.S.Sathyabhama,
Major Haemorrhage Management
Coagulopathy and blood component transfusion in trauma
Blood Components Dosage And Their Administration
Use Fixed low dose Prothrombin Complex Concentrate (Octaplex)
Presentation transcript:

Transfusion Management of Massive Haemorrhage in Adults Patient bleeding / collapses Ongoing severe bleeding eg: 150 mls/min and Clinical shock Administer Tranexamic Acid – esp in trauma and ideally within 1 hour (1g bolus followed by 1g infusion over 8 hours) Patient bleeding / collapses Ongoing severe bleeding eg: 150 mls/min and Clinical shock Administer Tranexamic Acid – esp in trauma and ideally within 1 hour (1g bolus followed by 1g infusion over 8 hours) Call for help ‘Massive Haemorrhage, Location, Specialty’ Alert emergency response team (including blood transfusion laboratory, portering/ transport staff) Consultant involvement essential Call for help ‘Massive Haemorrhage, Location, Specialty’ Alert emergency response team (including blood transfusion laboratory, portering/ transport staff) Consultant involvement essential Take bloods and send to lab : XM, FBC, PT, APTT, fibrinogen, U+E, Ca 2+ NPT: ABG, TEG / ROTEM if available and Order Massive Haemorrhage Pack 1 Red cells*4 units FFP4 units (*Emergency O blood, group specific blood, XM blood depending on availability) Take bloods and send to lab : XM, FBC, PT, APTT, fibrinogen, U+E, Ca 2+ NPT: ABG, TEG / ROTEM if available and Order Massive Haemorrhage Pack 1 Red cells*4 units FFP4 units (*Emergency O blood, group specific blood, XM blood depending on availability) Reassess Suspected continuing haemorrhage requiring further transfusion Take bloods and send to lab : FBC, PT, APTT, fibrinogen, U+E, Ca 2+ NPT: ABG, TEG / ROTEM if available Reassess Suspected continuing haemorrhage requiring further transfusion Take bloods and send to lab : FBC, PT, APTT, fibrinogen, U+E, Ca 2+ NPT: ABG, TEG / ROTEM if available Give MHP 2 Give MHP 2 Insert local arrangements: Activation Tel Number(s) Emergency O red cells - location of supply: * Time to receive at this clinical area: Group specific red cells XM red cells Insert local arrangements: Activation Tel Number(s) Emergency O red cells - location of supply: * Time to receive at this clinical area: Group specific red cells XM red cells STOP THE BLEEDING RESUSCITATE Ai rway Breathing Circulation Haemorrhage Control Direct pressure / tourniquet if appropriate Stabilise fractures Surgical intervention – consider damage control surgery Interventional radiology Endoscopic techniques Haemorrhage Control Direct pressure / tourniquet if appropriate Stabilise fractures Surgical intervention – consider damage control surgery Interventional radiology Endoscopic techniques Haemostatic Drugs Vit K and Prothrombin complex concentrate for warfarinised patients and Other haemostatic agents and reversal of new anticoagulants: discuss with Consultant Haematologist Haemostatic Drugs Vit K and Prothrombin complex concentrate for warfarinised patients and Other haemostatic agents and reversal of new anticoagulants: discuss with Consultant Haematologist Prevent Hypothermia Use fluid warming device Used forced air warming blanket Prevent Hypothermia Use fluid warming device Used forced air warming blanket Cell salvage if available and appropriate Consider ratios of other components: 1 unit of red cells = c.250 mls salvaged blood Cell salvage if available and appropriate Consider ratios of other components: 1 unit of red cells = c.250 mls salvaged blood Consider 10 mls Calcium chloride 10% over 10 mins 2 packs cryoprecipitate if fibrinogen < 1.5g/L or as guided by TEG / ROTEM (< 2g/L for obstetric haemorrhage) Aims for therapy Aim for: Hb80-100g/L Platelets>75 x 10 9 /L PT ratio< 1.5 APTT ratio<1.5 Fibrinogen>1.5g/L Ca 2+ >1 mmol/L Temp > 36 o C pH > 7.35 (on ABG) Monitor for hyperkalaemia Aims for therapy Aim for: Hb80-100g/L Platelets>75 x 10 9 /L PT ratio< 1.5 APTT ratio<1.5 Fibrinogen>1.5g/L Ca 2+ >1 mmol/L Temp > 36 o C pH > 7.35 (on ABG) Monitor for hyperkalaemia STAND DOWN Inform lab Return unused components Complete documentation Including audit proforma Transfusion lab  Consultant Haematologist  Transfusion lab  Consultant Haematologist  Thromboprophylaxis should be considered when patient stable Give MHP 1 ABG – Arterial Blood Gas APTT – Activated partial thromboplastin time ATD- Adult Therapeutic Dose FFP- Fresh Frozen plasma MHP – Massive Haemorrhage Pack NPT – Near Patient Testing PT- Prothrombin Time TEG/ROTEM- Thromboelastography XM - Crossmatch Order Massive Haemorrhage Pack 2 Red cells4 units FFP4 units Platelets 1 dose (ATD) and subsequently request Cryoprecipitate 2 packs if fibrinogen <1.5g/l or according to TEG / ROTEM (<2g/l for obstetric haemorrhage) Order Massive Haemorrhage Pack 2 Red cells4 units FFP4 units Platelets 1 dose (ATD) and subsequently request Cryoprecipitate 2 packs if fibrinogen <1.5g/l or according to TEG / ROTEM (<2g/l for obstetric haemorrhage) Once MHP 2 administered, repeat bloods: FBC, PT, APTT, fibrinogen, U+E, NPT: ABG, TEG / ROTEM if available To inform further blood component requesting Once MHP 2 administered, repeat bloods: FBC, PT, APTT, fibrinogen, U+E, NPT: ABG, TEG / ROTEM if available To inform further blood component requesting Activate Massive Haemorrhage Pathway Continuous cardiac monitoring V3 2013